Mechanism of phosphorylation in TREK channels offers therapeutic potential

A team led by Prof. Dr. Han Sun from the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) has elucidated an important mechanism in the function of TREK channels at an atomic level. The results, published in the journal Nature Communications, could facilitate the development of therapeutics for diseases such as ischemia, epilepsy, and depression.